Showing 9,481 - 9,500 results of 59,594 for search '(( a ((((teer decrease) OR (mean decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 0.78s Refine Results
  1. 9481

    Patterns of lifetime use of substances by gender. by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    “…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”
  2. 9482

    S1 Data - by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    “…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”
  3. 9483

    Factors associated with substance use. by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    “…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”
  4. 9484

    Factors associated with personality traits. by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    “…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”
  5. 9485
  6. 9486
  7. 9487
  8. 9488

    Table_1_Variation of Small and Large Wild Bee Communities Under Honeybee Pressure in Highly Diverse Natural Habitats.DOCX by Imre Demeter (11780864)

    Published 2021
    “…<p>During the study, the honeybee effects on wild bees were tested and hypothesized that smaller distances from beehives will increase competitions between honeybees and wild bees, while greater distances will have a deleterious effect on competition. The impact on species richness and diversity was tested with distances from beehives, considering that this may differ when large and small wild bee species are considered separately. …”
  9. 9489
  10. 9490

    Predictive Modeling of pH in an Aquaponics System Using Bayesian and Non-Bayesian Linear Regression to Inform System Maintenance by Jameson Mori (11236882)

    Published 2021
    “…These systems can be a good source of fresh food but must maintain a delicate balance between the water quality requirements of the fish, plants, and nitrifying bacteria or risk decreased production, disease, and death. …”
  11. 9491

    Data supporting this article. by Karel Joineau (21799908)

    Published 2025
    “…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”
  12. 9492

    Demographic and clinical data at baseline. by Karel Joineau (21799908)

    Published 2025
    “…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”
  13. 9493

    Changes in clinical variables. by Karel Joineau (21799908)

    Published 2025
    “…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”
  14. 9494

    Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors by Simon Schallenberg (12336598)

    Published 2023
    “…<p>Most inactivating p53 mutations result in a nuclear p53 accumulation – detectable by immunohistochemistry (IHC). p53 alterations leading to a complete lack of p53 protein and absence of immunostaining do also occur – not easily detectable by IHC. p16 is upregulated in p53 inactivated cells. …”
  15. 9495
  16. 9496
  17. 9497
  18. 9498
  19. 9499
  20. 9500